Approved for To treat thymidine kinase 2 deficiency in patients with symptom onset at 12 years of age or younger. 12.1 Mechanism of Action Administration of KYGEVVI is intended to incorporate the pyrimidine nucleosides, deoxycytidine and deoxythymidine, into skeletal muscle mitochondrial deoxyribonucleic acid… Side effects, costs, interactions, manufacturer, and generic alternatives sourced from…
Loading full data from Know Your Drugs Institute…